ATE449338T1 - Screening-verfahren für gastritis - Google Patents

Screening-verfahren für gastritis

Info

Publication number
ATE449338T1
ATE449338T1 AT03745056T AT03745056T ATE449338T1 AT E449338 T1 ATE449338 T1 AT E449338T1 AT 03745056 T AT03745056 T AT 03745056T AT 03745056 T AT03745056 T AT 03745056T AT E449338 T1 ATE449338 T1 AT E449338T1
Authority
AT
Austria
Prior art keywords
antibodies
gastritis
pepsinogen
concentration
atpase
Prior art date
Application number
AT03745056T
Other languages
English (en)
Inventor
Sven Mardh
Erik Mardh
Original Assignee
Atrophus Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atrophus Ab filed Critical Atrophus Ab
Application granted granted Critical
Publication of ATE449338T1 publication Critical patent/ATE449338T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/062Gastritis or peptic ulcer disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03745056T 2002-03-27 2003-03-21 Screening-verfahren für gastritis ATE449338T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0200974A SE0200974D0 (sv) 2002-03-27 2002-03-27 Screening method for gastritis
PCT/SE2003/000469 WO2003081248A1 (en) 2002-03-27 2003-03-21 Screening method for gastritis

Publications (1)

Publication Number Publication Date
ATE449338T1 true ATE449338T1 (de) 2009-12-15

Family

ID=20287443

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03745056T ATE449338T1 (de) 2002-03-27 2003-03-21 Screening-verfahren für gastritis

Country Status (10)

Country Link
EP (1) EP1488238B1 (de)
JP (1) JP2005521055A (de)
CN (1) CN1701235A (de)
AT (1) ATE449338T1 (de)
AU (1) AU2003216007A1 (de)
CA (1) CA2478891A1 (de)
DE (1) DE60330125D1 (de)
NZ (1) NZ535937A (de)
SE (1) SE0200974D0 (de)
WO (1) WO2003081248A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI119572B (fi) * 2004-03-05 2008-12-31 Biohit Oyj Menetelmä vatsan limakalvon tilan ennustamiseksi
RU2519646C2 (ru) * 2007-10-26 2014-06-20 Биохит Оий Способы и продукты для диагностики аутоиммунных заболеваний и рака желудка, связанного с атрофическим гастритом

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139840B4 (de) 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
IT1262895B (it) 1992-03-02 1996-07-22 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
CA2067603A1 (en) 1992-04-29 1993-10-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
US5524622A (en) 1994-09-20 1996-06-11 Oregon Health Sciences University Non-invasive method of determining inflammation of the gastrointestinal tract
US5879897A (en) 1996-09-23 1999-03-09 Wake Forest University Methods and compositions for the diagnosis of extraesophageal gastric reflux
US6067989A (en) 1997-02-26 2000-05-30 Oridion Medical, Ltd. Breath test for the diagnosis of Helicobacter pylori infection in the gastrointestinal tract
FI118653B (fi) * 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi

Also Published As

Publication number Publication date
EP1488238B1 (de) 2009-11-18
WO2003081248A1 (en) 2003-10-02
SE0200974D0 (sv) 2002-03-27
JP2005521055A (ja) 2005-07-14
EP1488238A1 (de) 2004-12-22
AU2003216007A1 (en) 2003-10-08
CA2478891A1 (en) 2003-10-02
CN1701235A (zh) 2005-11-23
DE60330125D1 (de) 2009-12-31
NZ535937A (en) 2006-08-31

Similar Documents

Publication Publication Date Title
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
DK1141728T3 (da) Påvisning af nyresygdom og behandling deraf
MY133942A (en) Reagent test strip for analyte determination having hemolyzing agent
DE60228557D1 (de) Candida-nachweis
ATE332667T1 (de) Verfahren und vorrichtung zur sammlung von physiologischen proben
ATE245937T1 (de) Überwachung physiologischer analyte
DE69910007D1 (de) Vorrichtung zum vorhersagen von physiologischen messwerten
ATE384476T1 (de) Diagnose- und/oder analysesystem am behandlungsort
DE60317422D1 (de) Mediator-stabilisierende Verbindung und Methoden zur Verwendung zur Detektion elektrochemischer Analyte
WO2004089187A3 (en) Caries risk test for predicting and assessing the risk of disease
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE69941627D1 (de) Für krebs
DE60025170D1 (de) Diagnostisches verfahren für asthma
ATE449338T1 (de) Screening-verfahren für gastritis
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
ATE410695T1 (de) Screening-verfahren für den prädiabetiszustand und screening-reagenz
DK1095271T3 (da) Fremgangsmåde til diagnose af hjertekar-sygdomme og tidlig aterosklerose
ATE421093T1 (de) Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten
DE60229513D1 (de) Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
WO2006026808A8 (en) Method of diagnosing and/or predicting the development of an allergic disorder
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
ATE261120T1 (de) Anhand der konduktivität normalisierte bestimmung von analyten in urin zur diagnose von krankheiten
ATE232299T1 (de) Immunoassay zur bestimmung von psa-act
DE59910326D1 (de) Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties